Epigenetics of Rheumatic Diseases
During the “Epigenetics of Rheumatic Diseases” session, attendees will look at epigenetic control of disease-relevant genes and the new medications targeting epigenetic mechanisms.
Christopher B. Wilson, MD, Bruce C. Richardson, MD, PhD, and Ian M. Adcock, PhD, will explain how epigenetic mechanisms control gene activation, help identify DNA demethylation and histone modifications as critical mechanisms in autoimmune diseases, and offer suggestions on the potential of histone acetylation as a therapeutic target in inflammatory disease.
“Epigenetics of Rheumatic Diseases” will be held Tuesday, October 28 from 4:30–6:00 p.m.
Finally, to help attendees maximize their time at this year’s meeting, Dr. Mandell and the AMPC have made the following changes:
- Encore Theater presentations will be expanded to include television transmission into selected hotels;
- Special tours of the poster presentations will be led by academic leaders with expertise in the specific content areas; and
- Study group times will be expanded into the lunch hour to permit more attendees to participate.
For more information about the 2008 ACR/ARHP Annual Scientific Meeting, visit www.rheumatology.org/annual.
